BCL10 antibody (AA 35-51)
Quick Overview for BCL10 antibody (AA 35-51) (ABIN2617505)
Target
See all BCL10 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 35-51
-
Specificity
- Ubiquitous.
-
Cross-Reactivity (Details)
- No cross reactivity with other proteins.
-
Purification
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminus of human Bcl10(35-51aa ERHFDHLRAKKILSRED), identical to the related rat and mouse sequences.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Preservative
- Sodium azide, Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Alternative Name
- BCL10 / BCL-10
-
Background
-
Name/Gene ID: BCL10
Family: Apoptosis
Synonyms: BCL10, Bcl-10, B-cell CLL/lymphoma 10, B-cell lymphoma/leukemia 10, CARMEN, CARD-like apoptotic protein, CCARMEN, C-E10, CIPER, Cellular-E10, HCLAP, Cellular homolog of vCARMEN, CLAP, ME10 -
Gene ID
- 8915
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
Target
-